UBS AM’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-24,167
| Closed | -$1.35M | – | 2857 |
|
|
2018
Q4 | $1.35M | Buy |
24,167
+3,576
| +17% | +$194K | ﹤0.01% | 1608 |
|
|
2018
Q3 | $956K | Hold |
20,591
| – | – | ﹤0.01% | 1828 |
|
|
2018
Q2 | $994K | Sell |
20,591
-635
| -3% | -$30.4K | ﹤0.01% | 1814 |
|
|
2018
Q1 | $919K | Buy |
21,226
+5,925
| +39% | +$266K | ﹤0.01% | 1817 |
|
|
2017
Q4 | $607K | Buy |
15,301
+2,700
| +21% | +$113K | ﹤0.01% | 1910 |
|
|
2017
Q3 | $547K | Buy |
12,601
+648
| +5% | +$29.6K | ﹤0.01% | 1912 |
|
|
2017
Q2 | $572K | Sell |
11,953
-1,936
| -14% | -$90.3K | ﹤0.01% | 1839 |
|
|
2017
Q1 | $570K | Buy |
13,889
+7,189
| +107% | +$300K | ﹤0.01% | 1818 |
|
|
2016
Q4 | $257K | Sell |
6,700
-7,239
| -52% | -$294K | ﹤0.01% | 1997 |
|
|
2016
Q3 | $749K | Hold |
13,939
| – | – | ﹤0.01% | 1794 |
|
|
2016
Q2 | $600K | Buy |
13,939
+1,600
| +13% | +$67.1K | ﹤0.01% | 1866 |
|
|
2016
Q1 | $623K | Sell |
12,339
-366,244
| -97% | -$17.6M | ﹤0.01% | 1828 |
|
|
2015
Q4 | $24M | Buy |
378,583
+3,152
| +0.8% | +$215K | 0.03% | 603 |
|
|
2015
Q3 | $24.6M | Buy |
375,431
+59,984
| +19% | +$3.98M | 0.03% | 611 |
|
|
2015
Q2 | $21.4M | Buy |
315,447
+28,905
| +10% | +$1.59M | 0.02% | 702 |
|
|
2015
Q1 | $12.2M | Sell |
286,542
-2,861
| -1% | -$127K | 0.01% | 825 |
|
|
2014
Q4 | $14.3M | Sell |
289,403
-600
| -0.2% | -$24K | 0.01% | 786 |
|
|
2014
Q3 | $8.33M | Buy |
290,003
+173,603
| +149% | +$4.71M | 0.01% | 894 |
|
|
2014
Q2 | $3.05M | Buy |
116,400
+110,897
| +2,015% | +$2.86M | ﹤0.01% | 1178 |
|
|
2014
Q1 | $307K | Hold |
5,503
| – | – | ﹤0.01% | 2163 |
|
|
2013
Q4 | $265K | Sell |
5,503
-200
| -4% | -$8.41K | ﹤0.01% | 2213 |
|
|
2013
Q3 | $240K | Hold |
5,703
| – | – | ﹤0.01% | 2221 |
|
|
2013
Q2 | $257K | Buy |
+5,703
| New | +$224K | ﹤0.01% | 2102 |
|
UBS AM's IMPV Position: Q1 2019 in Review
UBS AM sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 24,167 shares — an estimated $1.35M sold.
UBS AM first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $24.6M in Q3 2015. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- UBS AM reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- UBS AM sold 24,167 Imperva, Inc. shares in Q1 2019, an estimated $1.35M.
- UBS AM first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
- UBS AM's Imperva, Inc. position peaked at $24.6M in Q3 2015.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.